In addition to the approach discussed in this study—modulating lipid metabolism to reduce the number or activity of MDSCs—inhibition of GLUTS, which is overexpressed on CD205+ PMN-MDSCs, has been shown to potentially restore antitumor immunity, as proved in a breast cancer model [124]. This evidence concerns the gene LY75 and breast carcinoma.